|
DEK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.563800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.211400E-04 |
| Normal-vs-Stage2 |
1.630770E-01 |
| Normal-vs-Stage3 |
6.979600E-01 |
| Normal-vs-Stage4 |
7.875200E-01 |
| Stage1-vs-Stage2 |
5.825000E-01 |
| Stage1-vs-Stage3 |
3.742000E-02 |
| Stage1-vs-Stage4 |
2.275000E-01 |
| Stage2-vs-Stage3 |
2.099800E-01 |
| Stage2-vs-Stage4 |
5.085400E-01 |
| Stage3-vs-Stage4 |
6.718800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.961700E-03 |
| Normal-vs-AfricanAmerican |
6.660300E-02 |
| Normal-vs-Asian |
4.444500E-02 |
| Caucasian-vs-AfricanAmerican |
6.833800E-01 |
| Caucasian-vs-Asian |
7.308200E-01 |
| AfricanAmerican-vs-Asian |
6.134800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.60680000000202E-05 |
| Normal-vs-Female |
4.954800E-01 |
| Male-vs-Female |
3.757400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.952500E-02 |
| Normal-vs-Extreme_Weight |
2.10829999999218E-05 |
| Normal-vs-Obese |
7.028600E-01 |
| Normal-vs-Extreme_Obese |
1.596740E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.139200E-01 |
| Normal_Weight-vs-Obese |
1.354600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.410000E-01 |
| Extreme_Weight-vs-Obese |
4.903600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.081200E-01 |
| Obese-vs-Extreme_Obese |
5.439800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.831000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.137980E-01 |
| Normal-vs-Age(61-80Yrs) |
3.047000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.020760E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.814190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.514200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.750190E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.788100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.630400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.704640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.009500E-04 |
| Normal-VS-Type2 PRCC |
6.551700E-04 |
| Normal-VS-KIRP CIMP |
4.527600E-02 |
| Normal-VS-Unclassified PRCC |
2.320200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.053000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.425630E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.811600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.239880E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.852380E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.516200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52750000004254E-06 |
| Normal-vs-N1 |
5.943900E-02 |
| Normal-vs-N2 |
6.948000E-02 |
| N0-vs-N1 |
5.613600E-04 |
| N0-vs-N2 |
6.782200E-01 |
| N1-vs-N2 |
1.625980E-01 |
|
|
